Nsk Corporation

Takeda Pharmaceutical Company Limited

Tokyo Medical and Dental University

The Rockefeller University

Takeda Pharmaceutical Company Limied

Scohia Pharma, Inc.

Institute of Science Tokyo

Hideki Furukawa

Toshiaki Oguchi

Yasuhiro Kawai

Tomoyuki Yanagisawa

Minoru Kubokawa

Koji Watanabe

Tomohiro Okawa

Nobuyuki Takakura

Yasufumi Miyamoto

Shizuo Kasai

Jumpei Aida

Yasuhiro Hirata

Seiji Miwatashi

Takatoshi Yogo

Yuko Hitomi

Naoyoshi Noguchi

Tetsuya Nagata

Takanori Yokota

Tsuyoshi Maekawa

Shigekazu Sasaki

Akito Shibuya

Toshitake Kobayashi

Tomohiro Seki

Kosuke Hidaka

Yayoi Nakayama

Yasuo Nakagawa

Kousuke Hidaka

Kenichi Miyata

Ryosuke Tokunoh

Yayoi Yoshitomi

Satoshi Sasaki

Takeshi Yamasaki

Norihito Tokunaga

Kazuaki Takami

Minoru Sasaki

Shigemitsu Matsumoto

Yuta Tanaka

Keisuke Yokoyama

Yoshito Terao

Michael Andrew Foley

Moriteru Asano

Kunihiko Sasao

Kazuyoshi Aso

Toshiki Murata

Masashi Takahashi

Tarun M Kapoor

Yoshiyuki Fukase

Ryoma Hara

Nobuko Okutani

Yusuke Adachi

Kyoko Toyofuku

Yashuhiro Hirata

Sachie Takashima

Akio Uchida

Naoto Arimura

The object of the present invention is to provide a nucleic acid agent that can be efficiently delivered to the nervous system, particularly the central nervous system to which the BBB mechanism prevents drug delivery, and can produce an antisense effect on a target transcriptional product at the delivered site, and a composition comprising the same. Provided is a double-stranded nucleic acid complex formed by annealing a first nucleic acid strand capable of hybridizing to part of a target transcriptional product, and has an antisense effect on the target transcriptional product, to a second nucleic acid strand comprising a base sequence complementary to the first nucleic acid strand, and is bound to tocopherol or an analog thereof, cholesterol or an analog thereof, or a substituted or unsubstituted Calkyl group, a substituted or unsubstituted Calkenyl group, or a substituted or unsubstituted Calkoxy group.

BBB-crossing lipid ligand of hetero nucleic acid

Developed and provided is: a nucleic acid agent that is efficiently delivered to the central nervous system, to which drug delivery is inhibited by the blood brain barrier mechanism, and that provides an antisense effect to a target transcription product at the delivery site; and a composition containing such a nucleic acid agent. Provided is a double-stranded nucleic acid complex consisting of a first nucleic acid strand and a second nucleic acid strand that are annealed to each other; wherein the first nucleic acid strand hybridizes with part of a target transcription product and has an antisense effect on the target transcription product; and wherein the second nucleic acid strand includes a base sequence complementary to the first nucleic acid strand and is conjugated to a phosphatidylethanolamine or an analog thereof.

Nucleic acid complex

A sensor includes a generator configured to generate a predetermined detection target, a detector configured to detect the detection target generated by the generator, and a substrate provided with the generator and the detector. The substrate includes a first portion provided with the generator, a second portion provided with the detector, a bent portion that is bent between the first portion and the second portion such that the generator and the detector face each other, and a ground pattern provided in a portion including the first portion, the second portion, and the bent portion. In the ground pattern, a ground pattern of the bent portion is narrower than a ground pattern of the first portion and a ground pattern of the second portion.

Sensor, sensor substrate, and sensor manufacturing method

Compounds of formula: are useful as antitumor agents. In these compounds, Ris (a) (C-C) hydrocarbyl, (C-C)halohydrocarbyl, (C-C)hydroxyalkyl, or or Ris (b) in which Q and A are linkers and Ar is optionally substituted monocyclic or bicyclic aryl or heteroaryl.

Pyrazoloquinazolinone antitumor agents

Provided is a novel aromatic ring compound which may have a GPR40 agonist activity and a GLP-1 secretagogue action. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof may have a GPR40 agonist activity and a GLP-1 secretagogue action, may be useful for the prophylaxis or treatment of cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia and the like, and may afford superior efficacy.

Aromatic compound

The present invention aims to provide a heterocyclic compound having an IP6K inhibitory action and expected to be useful as a prophylactic or therapeutic agent for&#x2014;diseases such as cardiac failure, diabetes and the like. A compound represented by the formula (I): wherein each symbol is as defined in the SPECIFICATION, or a salt thereof has an IP6K inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for diseases such as cardiac failure, diabetes and the like. 

IP6K inhibitors

Provided is a novel aromatic ring compound which may have a GPR40 agonist activity and a GLP-1 secretagogue action. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof may have a GPR40 agonist activity and a GLP-1 secretagogue action, may be useful for the prophylaxis or treatment of cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia and the like, and may afford superior efficacy. 

Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders

A sensor configured to detect displacement of a rotation angle of a shaft due to a rotation or a turn of the shaft, the sensor includes: a bearing rotatably supporting the shaft; and a housing including a bearing hole to which the bearing is fixed. The shaft and an inner circumferential surface of the bearing are fixed to each other by an adhesive agent, and an outer circumferential surface of the bearing and an inner circumferential surface of the bearing hole of the housing are fixed to each other by an adhesive agent.

Sensor

A sensor manufacturing method is a method for manufacturing a sensor including a generator that generates a predetermined detection target, a detector that detects the detection target generated by the generator, and a motion body that performs motion in the area in between the generator and the detector. In the method, the generator and the detector are positioned opposite to each other by either curving or bending a substrate including a first portion having the generator installed thereon and a second portion having the detector installed thereon that are formed in an integrated manner, and the substrate and the motion body are made to perform relative movement in such a way that the motion body enters the area in between the generator and the detector.

Sensor manufacturing method and sensor

A sensor including a generating unit; a detecting unit; a substrate; a member that exerts influence on an object to be detected; and a housing that includes a first housing that operably supports the member and a second housing to which a part of the substrate is fixed. The substrate includes a first portion provided with the generating unit and a second portion provided with the detecting unit that are integrated, and has a curved shape or a bent shape in which a surface of the first portion at which the generating unit is provided and a surface of the second portion at which the detecting unit is provided face each other. One of the first portion and the second portion is fixed to the second housing. A surface of the other of the first portion and the second portion adheres to the first housing.

Sensor having generating and detecting units on a substrate with a curve or bent shape in a cylindrical housing and method of manufacturing sensor

A target substance capturing device includes a reflection surface on which a plurality of non-flat portions is arrayed, the reflection surface capturing a target substance, and reflecting irradiated light. The plurality of non-flat portions are arranged in an array, the array includes a plurality of unit arrays in which the plurality of non-flat portions are arranged such that each one center of the non-flat portions superposes a position of a vertex in an M-time symmetrical figure, and the plurality of unit arrays is arranged such that each one center of gravity of the M-time symmetrical figure superposes a position of an intersection of an N-time symmetrical lattice pattern, where M is an integer of two or more, and N is an integer of two or more and different from M.

Target substance capturing device

A sensor including: a generating unit; a detecting unit that detects the object to be detected generated by the generating unit; and a substrate at which the generating unit and the detecting unit are provided. The substrate is a flexible substrate that includes a first portion provided with the generating unit and a second portion provided with the detecting unit, the first portion and the second portion being integrated, and that takes a curved shape or a bent shape in which a surface of the first portion at which the generating unit is provided and a surface of the second portion at which the detecting unit is provided face each other. A plate support member is attached to a back-side surface of at least one of the surface of the first portion and the surface of the second portion.

Sensor and method of manufacturing sensor

An optical sensor including a light-emitting element, four light-receiving elements facing the light-emitting element, and a substrate at which the light-emitting element and the light-receiving elements are provided. The substrate includes a first portion at which the light-emitting element is provided and a second portion at which the light-receiving elements are provided, the first portion and the second portion being integrated. Respective distances from the four light-receiving elements to one point on a predetermined plane are equal, four line segments that connect the one point and centers of respective light-receiving regions of the four light-receiving elements form right angles with each other, and a normal line of the predetermined plane that passes through the one point passes through an emission point of the light of the light-emitting element or a center of an emission surface of the light of the light-emitting element.

Optical sensor

Provided is a novel aromatic ring compound having a GPR40 agonist activity and a GLP-1 secretagogue action. A compound represented by the formula: wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity and a GLP-1 secretagogue action, is useful for the prophylaxis or treatment of cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia and the like, and affords superior efficacy.

Aromatic compounds with GPR40 agonistic activity

Provided is an aromatic ring compound having a glucagon antagonistic action, which is useful for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a salt thereof has a superior glucagon antagonistic action, and is useful as a glucagon antagonist, a glucose production inhibitor or an agent for the prophylaxis or treatment of diabetes and the like.

Aromatic ring compound

Growing community of inventors

Kanagawa, Japan

Hideki Furukawa